Compare NextEra Energy, Inc. (NEE) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs Natera Inc. Common Stock — how do they compare? NextEra Energy, Inc. trades at $79.73 (market cap $163.48B), while Natera Inc. Common Stock trades at $392.78 (market cap $57.03B). The key difference: NextEra Energy, Inc. is far larger — about 2.9× Natera Inc. Common Stock's market cap, and NextEra Energy, Inc. pays a 3.18% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NextEra Energy, Inc. for 83 Days and Natera Inc. Common Stock for 0 Days on average.
| NEE | NTRA | |
|---|---|---|
Market Cap | $163.48B | $57.03B |
Volume | 11,050,036 | 1,131,157 |
Sector | Utilities | Health |
52-Week High | $97.88 | $425.64 |
52-Week Low | $75.49 | $179.42 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $270.81B | $56.18B |
Dividend Yield | 3.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $78.22, down 0.37% on the day, with a bullish technical signal but mixed momentum indicators. The company reported strong earnings beats in Q1 and Q2 2026, with revenue of $27.41B in 2025 and a net income margin of 32.4%. Recent news highlights growth initiatives, including a $22.3B energy infrastructure project in Texas. The stock is supported by a consensus price target of $95.60, implying significant upside from current levels.
NEE presents a favorable investment case driven by robust profitability, strategic expansion in clean energy, and strong analyst support. However, risks include rising debt levels, with debt-to-asset ratio increasing to 47.6% in 2025, and sensitivity to interest rate changes. The stock's current valuation metrics, such as a P/E of 17.61, appear reasonable relative to growth prospects, but investors should monitor execution on large-scale projects and regulatory developments.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
